The Recall Desk
Agency classClass IIOur severity:SevereFDA (Devices)·Z-2671-2017·Announced 2017-07-12

CareFusion Recalls Alaris PC Unit 8015 Due to Infusion Interruption Risk

CareFusion 303, Inc. is recalling Alaris PC Unit Model 8015 devices because a software error can interrupt infusions.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a medical device defect that can interrupt infusions, posing a significant risk of harm to patients.

Plain-English summary

CareFusion 303, Inc. is recalling Alaris PC Unit Model 8015 medical devices. The recall involves 568,283 units that were distributed nationwide in the United States and internationally to Europe, Australia, New Zealand, South Africa, Greater Asia, the Middle East, and Canada.

The recall was initiated after the firm identified five scenarios that can trigger Systems Error Code 255-16-275. This error can potentially result in interrupted infusions. The recall applies to customers using software versions greater than 9.12.

Healthcare facilities and customers should contact CareFusion 303, Inc. for instructions on how to address the software issue and ensure patient safety.

The recalled product

Product
Alaris PC Unit, Model 8015
Affected units
568,283

Distribution

Distributed nationwide across the United States.

Similar recalls